XYMOGEN Launches A New Paradigm In Joint Tissue Health

ORLANDO, Fla., Oct. 29, 2013 /PRNewswire/ -- Orlando-based nutraceutical company XYMOGEN announced today the launch of SynovX, the latest in the business's lineup of professional dietary supplements. 

The SynovX line introduces three formulas—SynovX Performance, SynovX Tendon & Ligament and SynovX Metabolic—which are designed to support metabolism and the definitive needs of joint support associated with exercise.  Each supplement contains specific ingredients to address discomfort while stimulating muscle function. These new formulas reflect the latest research and developments in the area of joint health.     

"XYMOGEN has had the SynovX line in development for some time now," said CEO Brian Blackburn, "After years of research, we have finally achieved the optimal formulas to address the needs of patients and healthcare practitioners.  Each of the SynovX supplements upholds the company's high standards of quality in our product offerings."

XYMOGEN is renowned for its commitment to innovation in the healthcare industry.  The company attributes its reputation to a "People First" culture, which offers employees unprecedented opportunities for discovery, growth and fulfillment.  The business has earned numerous accolades and was recently named for a sixth time to INC Magazine's list of the nation's fastest growing private companies.  

About XYMOGEN

XYMOGEN, a family-owned, health sciences company with headquarters in Orlando, Fla., has been providing high-quality dietary supplements to licensed health care practitioners for more than a quarter century.

The nutraceutical company has introduced numerous innovations to the functional medicine community; its Medical Board of Advisors consists of clinical practitioners who represent a broad range of specialties.

XYMOGEN's strength as a company was reinforced in 2007, 2008, 2010, 2011, 2012 and 2013 when it was recognized by Inc. Magazine as one of the 5,000 fastest-growing, best-run, most innovative and most inspiring private companies in America.

The company's 136,000-square-foot manufacturing facility is GMP (good manufacturing practices) and GMP for Sport Athletic Banned Substances Program registered by NSF International.

More information is available at www.xymogen.com

Please email [email protected] for comments or inquiries.

For information, contact:
Kristin Colville
407-702-6634
[email protected]

Distributed by Sara Brady Public Relations, Inc.
222 W. Comstock Avenue, Suite 215
Winter Park, Florida  32789
407-702-6632
www.sarabradypr.com

SOURCE XYMOGEN

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED